ASRI: Global Patent Filings For Novel Empathogens, Tryptamines
28 May 2024 //
PR NEWSWIRE
Enveric Strengthens IP with New U.S. Patent for Tryptamine-derived Prodrugs
28 Aug 2023 //
BUSINESSWIRE
Enveric Bio Files Portfolio of Patent Applications for Tryptamine-Based Molecule
01 Mar 2022 //
PRNEWSWIRE
Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
19 Jan 2022 //
GLOBENEWSWIRE
Cybin Awarded Notice of Allowance from USPTO for CYB004 in Anxiety Disorders
15 Dec 2021 //
BUSINESSWIRE